NCT02590744

Brief Summary

This study is a single-center, prospective, randomized, controlled trial. To investigate if preoperative using of eye patch will decrease emergence agitation, and to provide a better method of decreasing emergence agitation to pediatric ophthalmic anesthesiologists.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

October 22, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 29, 2015

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

June 15, 2017

Status Verified

June 1, 2017

Enrollment Period

2 years

First QC Date

October 22, 2015

Last Update Submit

June 13, 2017

Conditions

Keywords

Emergence Agitationeye patchpreschool children

Outcome Measures

Primary Outcomes (1)

  • the Padiatric Anesthesia Emergence Agitation Scale

    measure patients with the pediatric anesthesia emergence agitation scale,the score more than 10 is defined as emergence agitation.

    every ten minutes postoperatively, up to 1 hour. Start measuring since the end of surgery until the patient back to ward from postanesthesia care unit.

Secondary Outcomes (5)

  • induction compliance checklist

    1 minute before general anesthesia began.

  • heart rate (HR)

    every ten minutes postoperatively, up to 1 hour. Start measuring since every ten minutes postoperatively, up to 1 hour. Start measuring since the end of surgery until the patient back to ward from postanesthesia care unit.

  • respiration rate(RR)

    every ten minutes postoperatively, up to 1 hour. Start measuring since the end of surgery until the patient back to ward from postanesthesia care unit.

  • oxygen saturation(SpO2)

    every ten minutes postoperatively, up to 1 hour. Start measuring since the end of surgery until the patient back to ward from postanesthesia care unit.

  • incidence rate of emergence agitation

    every ten minutes postoperatively, up to 1 hour. Start measuring since the end of surgery until the patient back to ward from postanesthesia care unit.

Study Arms (2)

eye patch

EXPERIMENTAL

cover the sick eye with eye patch for 3 hours preoperatively.

Behavioral: eye patch

non-eye patch

PLACEBO COMPARATOR

do not cover the sick eye before surgery.

Behavioral: non-eye patch

Interventions

eye patchBEHAVIORAL

cover the sick eye with eye patch preoperatively for 3 hours

Also known as: eye shade, eye shield
eye patch
non-eye patchBEHAVIORAL

do not cover the sick eye with eye patch preoperatively

Also known as: eye shade, eye shield
non-eye patch

Eligibility Criteria

Age3 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preschool patients undergo elective cataract surgery, whose age are 3 to 7 years.
  • Patients' parents agree to participate in the trial, and sigh the informed consent.

You may not qualify if:

  • Patient who can not communicate with medical workers preoperatively.
  • Both of patient's eyes are covered postoperatively.
  • Patient's parents refuse to sign informed consent.
  • The investigators do not think such patient is suitable for our research
  • The patient has serious arrhythmia, abnormal cardiac defect.
  • The patient has suffered from pneumonia, asthma symptoms, bronchitis, or upper respiratory tract infection recent two weeks.
  • The patient has serious disease of the nervous system.
  • The patient has the allergic history of any drug involved in this clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan ophthalmic center, Sun Yat-sen University

Guangzhou, Guangdong, 510080, China

RECRUITING

Related Publications (1)

  • Lin Y, Shen W, Liu Y, Wang Q, Chen Q, Fang Z, Chi W, Gan X, Liu YZ. Visual preconditioning reduces emergence delirium in children undergoing ophthalmic surgery: a randomised controlled trial. Br J Anaesth. 2018 Aug;121(2):476-482. doi: 10.1016/j.bja.2018.03.033. Epub 2018 May 25.

MeSH Terms

Conditions

Psychomotor AgitationEmergence Delirium

Condition Hierarchy (Ancestors)

DyskinesiasNeurologic ManifestationsNervous System DiseasesPsychomotor DisordersNeurobehavioral ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsAberrant Motor Behavior in DementiaBehavioral SymptomsBehaviorDeliriumConfusionPostoperative ComplicationsPathologic ProcessesNeurocognitive DisordersMental Disorders

Study Officials

  • Yizhi Liu, PhD

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    STUDY CHAIR

Central Study Contacts

Xiaoliang Gan, PhD

CONTACT

Yiquan Lin, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
associate chief physician

Study Record Dates

First Submitted

October 22, 2015

First Posted

October 29, 2015

Study Start

October 1, 2015

Primary Completion

October 1, 2017

Study Completion

October 1, 2017

Last Updated

June 15, 2017

Record last verified: 2017-06

Locations